How IT is Transforming Biotech with AI | Anthony Murabito on Data, Security & Innovation
As new AI tools sweep into biotech, companies are racing to harness their power for faster discoveries and smarter workflows.
I sat down with Anthony Murabito to see how IT steers research, security, and growth at Wave Life Sciences. As VP of IT and Head of Data Security, he’s overseen everything from early word-processing rollouts to rolling out AI across R&D and commercial teams.
We talk about winning over senior leaders, crafting AI policies, and keeping data locked down. We compare AI’s impact on R&D (pharmacology and tox modeling) versus commercial teams (automatic summaries and reporting). And Tony offers a simple mantra for new biotech CIOs: learn the business, treat your team as partners, and measure wins by the value you deliver.
Tune in to hear Tony’s practical tips and rethink what your IT team can achieve.
Specifically, this episode highlights the following themes:
- Embedding IT in research and commercial workflows for maximum impact
- Building robust AI governance with policies, training, and data-protection contracts
- Cultivating business-driven relationships and team ownership
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Anthony Murabito: https://www.linkedin.com/in/tonymurabito
- Learn more about Wave Life Sciences: https://www.wavelifesciences.com
==== Time Stamps ====
00:00 – Introduction
01:24 – Tony’s path from pharmacy school to IT leadership
08:10 – Early wins: cutting letter turnaround from 30 to 10 days
13:17 – Crafting AI policies and data-protection agreements
20:53 – AI in R&D vs. commercial teams: key use cases
24:26 – Top advice for a new biotech CIO
30:00 – Fostering team ownership and continuous learning
34:56 – Tony’s standout live-music memory
